https://www.nzdoctor.co.nz/everybody-patient-sheets

General Practice

Gordon Royle pradaxa
+Clinical

New Zealand contributes to trial success for dabigatran reversal

New Zealanders made up about a third of participants when idarucizumab was trialled internationally for reversing anti-coagulation

Read more
By Virginia McMillan
Friday 18 August 2017, 05:21 PM
0
Back to The newspaper

Article archive

Latest news

Lost tribe of doctors who missed the lessons in work–life balance

20/09/2019
0

PMAANZ leads charge to upskill practice managers and protect their careers

20/09/2019
0

Frailty: It’s a medical condition

20/09/2019
0

Rediscovering your wairua crucial to trauma recovery for Māori

19/09/2019
0

Posters and tactful questions the best way to uncover family violence

19/09/2019
0

More brand changes coming up for patients with mental health issues

18/09/2019
1

Mobile dental units filling gaps in Northland oral health treatment

18/09/2019
0

Risk/benefit tool developed to assess which patients gain from aspirin

18/09/2019
0

New efforts to devolve non-acute care to community an ‘exciting opportunity’

18/09/2019
4

GP leads call on MPs to take Mirena cost burden off women’s shoulders

17/09/2019
0

Tearful departure from ‘wonderful role’ for practice managers’ chair

17/09/2019
0

Mental health roles fleshed out to add support in general practice

16/09/2019
2

Canterbury DHB criticised after four ED visits needed to diagnose strokes

16/09/2019
0

Monday Memo: 16 September 2019

16/09/2019
0

Symbicort gets the green light for patients with mild asthma

16/09/2019
0

When lifestyle’s the way to bring back lost periods. Amen to that

16/09/2019
0

Patients seeking measles vaccine turned away as shortage bites

13/09/2019
1

Latest issue

Cover 11 September 2019

11 September 2019

View all issues

Facebook

New Zealand Doctor

Twitter